UNSPSC 51382603: Tybamate

This classification denotes a carbamate anxiolytic with the molecular formula C13H26N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3875LLL8M8, chemically known as [2-(carbamoyloxymethyl)-2-methylpentyl] N-butylcarbamate but generally known as tybamate, which bears US NIH Compound Identifier 20266. European Medicines Agency schedules tybamate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11369MIG. Most nations schedule tybamate under HS 29241900 and SITC 51471.

As of Q4 2014, TYBAMATE remains the US FDA Preferred Term for this commodity. Tybamate bears US NLM identifiers UMLS ID C0175163 and NCI Concept Code C98240. SMILES: CCCCNC(=O)OCC(C)(CCC)COC(=O)N.

UNSPSC 51382603 Tybamate is a Commodity code that in recent state and local procurement activity encompasses pharmaceutical products, naloxone, drug deactivation systems, and generic multi-source medications procured through competitive bidding and cooperative purchasing vehicles. The code reflects what state and local health agencies, human services departments, and cooperative purchasing alliances actually buy: finished pharmaceutical products and overdose-response supplies for community health programs, rather than the chemical compound tybamate alone. Issuing bodies include county health departments, state health and human services commissions, and multistate cooperative purchasing alliances that serve participating state and local government facilities. The scope spans both specialized public health supplies (naloxone and drug deactivation systems for harm reduction) and routine generic pharmaceuticals and over-the-counter products distributed through established wholesaler networks with National Drug Code specifications and cGMP compliance requirements.

Recent activity centers on Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS (due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with contract terms of two years plus one-year renewal and potential FEMA funding. Texas Health and Human Services Commission posted RFI HHS0017013 (April 3, 2026) to gather vendor information on direct-to-manufacturer prescription programs and direct contracting capabilities for pharmacy benefit management outside traditional PBM and GPO channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with products required to be available by May 15, 2026 and contract effectiveness July 1, 2026. The RFP weighted price competitiveness at 75 percent, required cGMP and DSCSA compliance, and imposed a 3 percent administrative fee on all contract purchases.